Ophthalmology Practice Brokers vs. Investment Bankers
Expert Analysis Ophthalmology Practice Brokers vs. Investment Bankers The ophthalmology... Read more.
OB/GYN Practice Valuation Ranges: 2026
Expert Analysis
OB/GYN Practice Valuation Ranges: 2026
OB/GYN practices continue to draw meaningful investor attention in 2026, supported by steady demand for prenatal... Read more.
Medspa Valuation Multiples Dashboard (2026 Update)
Expert Analysis
Medspa Valuation Multiples Dashboard (2026 Update)
Medical aesthetics remains one of the strongest-performing categories in healthcare M&A,... Read more.
Orthodontic Practice Valuation: 2026 Report
Expert Analysis
Orthodontic Practice Valuation (2026 Update)
Updated November 2025
Orthodontic practices remain one of the most stable assets in healthcare M&A.... Read more.
Pediatric Dentistry Practice Valuation: 2025 Update
Expert Analysis
Pediatric Dentistry Practice Valuation (2025 Update)
Updated November 2025
Pediatric dentistry remains one of the most resilient and actively traded... Read more.
Healthcare EBITDA Multiples: 2026 Dashboard
2026 Market Data
Healthcare EBITDA Multiples: 2026 Dashboard
Healthcare M&A has entered a recalibration phase in 2026. Record activity and inflated pricing... Read more.
Ophthalmology Practice Valuation: 2026 Benchmarks
Expert Analysis
Ophthalmology Practice Valuation: 2026 Benchmarks
Private equity and strategic consolidators continue to view ophthalmology as one of the most attractive... Read more.
Women’s Health – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered six reported Women's Health transaction, marking a sharp increase in transaction activity compared to the end of last year.... Read more.
Urology – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered three reported urology practice acquisitions, continuing a pattern of smaller deal volume and larger deal size when compared... Read more.
Orthopedics – Q1 2022 Acquisition Activity and Outlook
The 1st quarter of 2022 delivered nine reported orthopedic practice acquisitions, continuing the trend of increasing deal volume.... Read more.
Ophthalmology – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered eleven reported ophthalmology practice acquisitions, marking a sharp decline from the flurry of closings at the end of last year... Read more.
Home Health & Hospice – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered twenty-eight reported home health and hospice acquisitions, coming down from peaks levels to end the past year However, Q1 has... Read more.
Gastroenterology – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered ten reported gastroenterology practice acquisitions, continuing the high level of M&A activity we saw last year Several deals... Read more.
ENT & Allergy – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered two reported ENT practice acquisitions, coming down from a flurry of deal activity to end last year.... Read more.
Dermatology – Q1 2022 Acquisition Activity and Outlook
The 4th quarter of 2021 delivered two reported cardiology platform acquisitions, signaling an imminent wave of increasing private equity investments into the specialty.... Read more.